13 research outputs found

    Mapping QTL for resistance to new virulent races of wheat stripe rust from two argentinean wheat cultivars

    No full text
    During the last two decades, new virulent and aggressive races of Puccinia striiformis Westend. f. sp. tritici (Pst) have spread worldwide, causing devastating epidemics and prompting the search for new sources of resistance in wheat (Triticum aestivum L.). Between 2012 and 2017, we mapped four stripe rust resistance quantitative trait loci (QTL) effective against the Pst races present in California, USA, using recombinant inbred lines (RILs) developed from the cross between the Argentinean cultivars ‘Klein Proteo’ and ‘Klein Chajá’. The RIL population showed transgressive segregation in all six growing seasons relative to the parental lines, which showed moderate levels of Pst resistance. Analyses by year detected QTL conferring adult plant resistance on chromosomes 1BL, 2BS, 3D centromeric (from Klein Chajá), and 4DL (from Klein Proteo). QYr.ucw-1BL, mapped in the Yr29 resistance gene region, was significant in all seasons (P < 0.01) and explained on average 31.0 to 32.8% of the observed variation. QYr.ucw-2BS showed a stronger effect than QYr.ucw-1BL in 2013 but was ineffective in 2014 and 2016. This QTL also conferred seedling resistance, suggesting that it is an all-stage resistance gene. Centromeric QYr.ucw-3D and QYr.ucw-4DL showed smaller effects than the previous QTL and were significant only in some of the experiments. No significant interactions were detected among QTL, indicating the absence of digenic epistatic effects. The molecular markers identified in this study can be used to combine these genes and accelerate their deployment in wheat breeding programs

    Genetics of inflammatory bowel disease

    No full text

    Determination of Traces of Mercury

    No full text

    Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study

    No full text
    Purpose: To evaluate patients with resolved versus confirmed ARDS, identify subgroups with substantial mortality risk, and to determine the utility of day 2 ARDS reclassification. Methods: Our primary objective, in this secondary LUNG SAFE analysis, was to compare outcome in patients with resolved versus confirmed ARDS after 24\ua0h. Secondary objectives included identifying factors associated with ARDS persistence and mortality, and the utility of day 2 ARDS reclassification. Results: Of 2377 patients fulfilling the ARDS definition on the first day of ARDS (day 1) and receiving invasive mechanical ventilation, 503 (24%) no longer fulfilled the ARDS definition the next day, 52% of whom initially had moderate or severe ARDS. Higher tidal volume on day 1 of ARDS was associated with confirmed ARDS [OR 1.07 (CI 1.01\u20131.13), P = 0.035]. Hospital mortality was 38% overall, ranging from 31% in resolved ARDS to 41% in confirmed ARDS, and 57% in confirmed severe ARDS at day 2. In both\ua0resolved and confirmed\ua0ARDS, age, non-respiratory SOFA score, lower PEEP and P/F ratio, higher peak pressure and respiratory rate were each\ua0associated with mortality. In confirmed ARDS, pH and the presence of immunosuppression or neoplasm were also associated\ua0with mortality. The increase in area under the receiver operating curve for ARDS reclassification on day 2 was marginal. Conclusions: ARDS, whether resolved or confirmed at day 2, has a high mortality rate. ARDS reclassification at day 2 has limited predictive value for mortality. The substantial mortality risk in severe confirmed ARDS suggests that complex interventions might best be tested in this population. Trial Registration: ClinicalTrials.gov NCT02010073. \ua9 2018, Springer-Verlag GmbH Germany, part of Springer Nature and ESICM
    corecore